Compare XGN & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XGN | AIXI |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.7M | 421.3K |
| IPO Year | 2014 | 2022 |
| Metric | XGN | AIXI |
|---|---|---|
| Price | $7.44 | $0.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.86 | N/A |
| AVG Volume (30 Days) | 434.6K | ★ 5.4M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.12 | $26.84 |
| Revenue Next Year | $13.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $0.08 |
| 52 Week High | $12.23 | $16.28 |
| Indicator | XGN | AIXI |
|---|---|---|
| Relative Strength Index (RSI) | 67.27 | 37.16 |
| Support Level | $4.08 | $0.26 |
| Resistance Level | $7.99 | $1.45 |
| Average True Range (ATR) | 0.38 | 0.17 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 66.55 | 9.89 |
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
XIAO-I Corp operates as a cognitive artificial intelligence company. Using its proprietary intellectual property technologies, the company has developed and commercialized various core technologies, such as Conversational AI, Knowledge Fusion, Intelligence Voice, Hyperautomation, Data Intelligence, Cloud, Intelligent Construction Support, Vision Analysis, Intelligent Hardware Support, and Metaverse. Additionally, it has developed Hua Zang Universal Large Language Model. XIAO-I offers two different product lines: Model as a service (MaaS) and non-MaaS. Key revenue is derived from the non-MaaS product line, which comprises needs assessment, solution design and architecture planning, development and configuration, deployment, and implementation of non-model (mainly cloud platform) products.